Working group and policy reports

Please select a publication from the list below to view the full details.

*
*

Testing antibody therapies

Publication Details:

In March 2006, six volunteers taking part in a phase I clinical trial of a monoclonal antibody, TGN1412, experienced severe adverse events. As part of the Academy of Medical Sciences’ on-going work into the research and development of new medicines, a small working group was convened to discuss some of the broad questions and issues arising from the TGN1412 trial.

Publication Downloads:
*
*
    Back to: